Drug Profile

GYKI 52466

Latest Information Update: 25 May 2001

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator IVAX Drug Research Institute
Class Antiepileptic drugs; Muscle relaxants; Neuroprotectants; Small molecules
Mechanism of Action AMPA receptor antagonists; Glutamate receptor antagonists

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

25 May 2001 Data have been added to the Neurological Disorders pharmacodynamics section
08 Aug 1995 Discontinued-Preclinical for Alzheimer's disease in Hungary (Unknown route)
08 Aug 1995 Discontinued-Preclinical for Alzheimer's disease in United Kingdom (Unknown route)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com